Evidence map›Paper›PMID 34001883›Full record

ArticleNature communications2021

NBR1 is a critical step in the repression of thermogenesis of p62-deficient adipocytes through PPARγ.

Jianfeng Huang, Juan F Linares, Angeles Duran, Wenmin Xia, Alan R Saltiel, Timo D Müller, Maria T Diaz-Meco, Jorge Moscat

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. NBR1: The archetypal selective autophagy receptor.The Journal of cell biology · 2022
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Jianfeng HuangSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Juan F LinaresDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Angeles DuranDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Wenmin XiaDivision of Metabolism and Endocrinology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
Alan R SaltielDivision of Metabolism and Endocrinology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0002-9726-9828
Timo D MüllerInstitute for Diabetes and Obesity, Helmholtz Diabetes Center at Helmholtz Centre Munich, Oberschleißheim, Germany.
Maria T Diaz-MecoDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.ORCID 0000-0003-0147-0998
Jorge MoscatDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. jom4010@med.cornell.edu.ORCID 0000-0002-9442-3834
Cornell University · USUniversity of California San Diego · USDeutsches Diabetes-Zentrum e.V. · DESanford Burnham Prebys Medical Discovery Institute · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Maximiliano A DAngelo · 1985 to 2026
$107.2M
Role of p62/SQSTM1 in obesity-induced liver cancerR01CA211794 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KARIN, MICHAEL, MOSCAT, JORGE · 2017 to 2021
$3.6M
Role of p62 in metabolic reprograming of the tumor stroma in prostate cancerR01CA218254 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI DIAZ MECO CONDE, MARIA TERESA, METALLO, CHRISTIAN MICHAEL · 2017 to 2021
$2.6M
Molecular mechanisms driving mesenchymal colorectal cancerR01CA250025 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MOSCAT, JORGE · 2021 to 2025
$2.2M
Control of stellate cells-driven liver cancer by the p62/NBR1 adaptersR01DK108743 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI MOSCAT, JORGE · 2016 to 2020
$2.2M
Novel Pathways in the Control of Lineage Plasticity in Neuroendocrine Prostate CancerR01CA246765 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI DIAZ MECO CONDE, MARIA TERESA · 2020 to 2024
$2.1M
NCI NIH HHS P30 CA030199NCI NIH HHS R01 CA211794NCI NIH HHS R01 CA218254NCI NIH HHS R01 CA246765NCI NIH HHS R01 CA250025NIDDK NIH HHS R01 DK108743
6 · The paper itself

Abstract

Activation of non-shivering thermogenesis is considered a promising approach to lower body weight in obesity. p62 deficiency in adipocytes reduces systemic energy expenditure but its role in sustaining mitochondrial function and thermogenesis remains unresolved. NBR1 shares a remarkable structural similarity with p62 and can interact with p62 through their respective PB1 domains. However, the physiological relevance of NBR1 in metabolism, as compared to that of p62, was not clear. Here we show that whole-body and adipocyte-specific ablation of NBR1 reverts the obesity phenotype induced by p62 deficiency by restoring global energy expenditure and thermogenesis in brown adipose tissue. Impaired adrenergic-induced browning of p62-deficient adipocytes is rescued by NBR1 inactivation, unveiling a negative role of NBR1 in thermogenesis under conditions of p62 loss. We demonstrate that upon p62 inactivation, NBR1 represses the activity of PPARγ, establishing an unexplored p62/NBR1-mediated paradigm in adipocyte thermogenesis that is critical for the control of obesity.

Indexed as

ThermogenesisAdipocytesAdipose Tissue, BrownAnimalsAnimals, NewbornCell NucleusCells, CulturedEnergy MetabolismHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicPPAR gammaIntracellular Signaling Peptides and ProteinsNbr1 protein, mousePPAR gammaRetinoid X Receptor alphaSequestosome-1 ProteinSqstm1 protein, mouse

Identifiers

PMID34001883
PMCPMC8129077
OpenAlexW3163179134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.